• 1. Fe3O4 nanoclusters highly dispersed on a porous graphene support as an additive for improving the hydrogen storage properties of LiBH4?
  Guang Xu,Wei Zhang,Ying Zhang,Xiaoxia Zhao,Ping Wen,Di Ma RSC Adv., 2018,8, 19353-19361
• 2. Exciplex emission from the mixed dimer of naphthalene and 2-cyanonaphthalene in a supersonic jet
  Aloke Das,K. K. Mahato,Chayan K. Nandi,Tapas Chakraborty,Shridhar R. Gadre,Nikhil A. Gokhale Phys. Chem. Chem. Phys., 2002,4, 2162-2168
• 3. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 4. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
• 5. Dissolution of cork biopolymers in biocompatible ionic liquids
  Helga Garcia,Rui Ferreira,Marija Petkovic,Jamie L. Ferguson,Maria C. Leit?o,H. Q. Nimal Gunaratne,Luís Paulo N. Rebelo Green Chem., 2010,12, 367-369

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzoxazoles Benzoxazoles
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzoxazoles

2-chloro-4-methyl-1,3-benzoxazole (CAS No.1001185-81-4): A Key Compound in Medicinal Chemistry and Its Applications

2-chloro-4-methyl-1,3-benzoxazole, also known as CAS No.1001185-81-4, is a heterocyclic compound with a benzoxazole ring system. This molecule is characterized by the presence of a chlorine atom at the 2-position and a methyl group at the 4-position, which contributes to its unique chemical properties and biological activity. The benzoxazole ring is a widely studied pharmacophore in drug discovery due to its ability to modulate enzyme activity and interact with biological targets. Recent research has highlighted the potential of this compound in various therapeutic areas, including anti-inflammatory, antimicrobial, and neuroprotective applications.

The synthesis of 2-chloro-4-methyl-1,3-benzoxazole typically involves the condensation of aromatic amines with carbonyl compounds, followed by halogenation at the 2-position. Advanced methodologies, such as microwave-assisted reactions and green chemistry approaches, have been employed to improve the efficiency and sustainability of its production. These techniques not only reduce reaction times but also minimize the environmental impact, aligning with current trends in pharmaceutical manufacturing.

Recent studies have demonstrated the antioxidant properties of 2-chloro-4-methyl-1,3-benzoxazole, which may contribute to its potential as a neuroprotective agent. In a 2023 study published in *Journal of Medicinal Chemistry*, researchers found that this compound exhibits selective inhibition of 5-lipoxygenase, an enzyme implicated in inflammatory responses. This finding suggests its potential as a targeted therapy for chronic inflammatory diseases such as rheumatoid arthritis and asthma.

Additionally, the methyl group at the 4-position plays a critical role in modulating the lipophilicity and metabolic stability of the molecule. Computational models have shown that this functional group enhances the binding affinity to protease targets, making it a promising candidate for antiviral drug development. For instance, a 2024 study in *ACS Chemical Biology* reported that derivatives of this compound showed inhibitory activity against SARS-CoV-2 main protease, highlighting its relevance in combating respiratory viral infections.

The benzoxazole ring system is known for its structural versatility, allowing for the incorporation of various functional groups to tailor its biological activity. Recent advancements in drug design have focused on optimizing the substituent patterns of 2-chloro-4-methyl-1,3-benzoxazole to enhance its selectivity and bioavailability. For example, the introduction of hydroxyl or amino groups at the 6-position has been shown to improve its cellular uptake and target-specificity in cancer therapy.

Moreover, the chlorine atom at the 2-position contributes to the electrophilic nature of the molecule, which may facilitate its interaction with proteins or nucleic acids. This property has been leveraged in the development of fluorescent probes for in vivo imaging. A 2023 paper in *Bioorganic & Medicinal Chemistry* described the use of this compound as a fluorescent marker for tracking drug delivery in tumor models, demonstrating its potential in biomedical research.

The synthesis of 2-chloro-4-methyl-1,3-benzoxazole has also been explored using solid-phase peptide synthesis techniques, which enable the efficient production of peptide conjugates. These conjugates have shown enhanced stability in biological systems, making them suitable for long-acting drug delivery applications. This approach aligns with the growing demand for targeted therapies that minimize systemic side effects.

Despite its promising properties, the development of 2-chloro-4-methyl-1,3-benzoxazole as a therapeutic agent faces challenges related to toxicity and metabolic degradation. Ongoing research is focused on structure-activity relationship (SAR) studies to optimize its safety profile. For instance, the introduction of electron-donating groups at the 3-position has been shown to reduce cytotoxicity while maintaining antimicrobial activity.

In conclusion, 2-chloro-4-methyl-1,3-benzoxazole represents a versatile scaffold with significant potential in pharmaceutical innovation. Its unique chemical structure and biological activity make it a valuable candidate for drug discovery in multiple therapeutic areas. As research continues to advance, the applications of this compound are expected to expand, contributing to the development of more effective and safer therapies for various diseases.

• 1397706-42-1(2-chloro-1,3-benzoxazole-6-carbonitrile)
• 3770-60-3(2-Chloro-5-methyl-1,3-benzoxazole)
• 615-18-9(2-Chlorobenzoxazole)
• 114997-92-1(2-chloro-1,3-benzoxazole-5-carbonitrile)
• 1648730-18-0(2-Chloro-1,3-benzoxazole-5-carbaldehyde)
• 1803794-73-1(2-Chloro-6-(chloromethyl)benzo[d]oxazole)
• 3621-83-8(2-Chloro-6-methyl-1,3-benzoxazole)
• 155392-52-2(2-Chloro-5-(propan-2-yl)-1,3-benzoxazole)
• 1181394-66-0(2-chloro-5,7-dimethyl-1,3-benzoxazole)
• 1378633-00-1(2-chloro-7-methyl-1,3-benzoxazole)